Genitourinary Radiology: Page 74

CEUS shows promise for monitoring prostate ablation

By Erik L. Ridley

ATLANTIC CITY - Contrast-enhanced ultrasound (CEUS) can precisely delineate thermal lesions from viable tissue, as well as guide and monitor radiofrequency (RF) ablation of the entire prostate, according to a presentation at this week's Leading Edge in Diagnostic Ultrasound conference.

May 23, 2006

Prostate health benefits from peppers, PSA screening

By Shalmali Pal

A new animal study by researchers from the U.S. and Japan found that capsaicin, the ingredient that gives chili peppers their kick, causes prostate cancer cells to self-destruct. Other studies by U.S. researchers examined the pathological characteristics of prostate cancers detected with prostate-specific antigen (PSA) testing, and the importance of PSA level after radiation therapy in predicting prostate cancer outcomes.

April 16, 2006

BrachySciences to sell TargetScan system

By AuntMinnie.com staff writers

Prostate brachytherapy implant developer BrachySciences of Oxford, CT, has signed a deal covering North American distribution of the TargetScan system from Envisioneering Medical Technologies of St. Louis.

March 27, 2006

F-18 fluoride PET/CT accurately detects bone metastases in high-risk prostate cancer

By Jonathan S. Batchelor

For high-risk prostate cancer patients, detecting osseous metastatic disease is critical in the management of their cancer. Recently, researchers from Israel studied planar bone scintigraphy, single and multiple field-of-view SPECT, PET, and PET/CT to see how they compared in detecting bone metastases in these patients.

March 9, 2006

NAS gets FDA clearance for brachytherapy needle kit

By AuntMinnie.com staff writers

Radiation therapy firm North American Scientific (NAS) has received Food and Drug Administration clearance to market its Prospera SurTrak line of brachytherapy products for the treatment of prostate cancer.

February 6, 2006

Chemical shift MRI improves detection of adrenal adenomas

By Radiology Review

(Radiology Review) Whether a coexisting adrenal mass is an adenoma or metastasis affects treatment of extra-adrenal primary tumors, according to researchers from Turkey. They report in the American Journal of Roentgenology that chemical shift MRI can help differentiate adrenal adenomas from nonadenomas and metastases.

January 18, 2006

GE, PhotoCure ink optical imaging deal

By AuntMinnie.com staff writers

GE Healthcare and PhotoCure have inked a licensing agreement covering the Oslo, Norway-based firm's Hexvix optical molecular imaging agent for diagnosing and monitoring bladder cancer.

January 8, 2006

IsoRay, IBt notch technology agreement

By AuntMinnie.com staff writers

Medical isotope developer IsoRay Medical has signed a letter of intent for a technology licensing agreement covering access to International Brachytherapy's (IBt) proprietary polymer seed technology for use with cesium-131 in brachytherapy.

January 2, 2006

CEUS-targeted biopsy bests US-guided systematic biopsy in prostate cancer detection

By Erik L. Ridley

Contrast-enhanced color Doppler ultrasound-targeted biopsy offers improvements in prostate cancer detection compared with grayscale ultrasound-guided systematic biopsy cores, according to researchers from the University Hospital Innsbruck in Vienna, Austria.

December 18, 2005

Low-field MR with the right coil tops 3-tesla MR for prostate cancer imaging

By Shalmali Pal

Until an endorectal coil specifically designed for use with the 3-tesla MR system is readily available, prostate imaging at 1.5 tesla will continue to be preferable, according to a report in the American Journal of Roentgenology.

December 14, 2005

HealthTronics taps new president and CEO

Healthcare firm HealthTronics of Austin, TX, has named a new president and CEO, and has announced that it may be selling its AK Specialty Vehicles mobile coach division.

December 4, 2005

Sonoblate 500 available in South Africa

By AuntMinnie.com staff writers

The South African subsidiary of high-intensity focused ultrasound (HIFU) developer U.S. HIFU of Charlotte, NC, has signed an agreement to bring the Sonoblate 500 technology to South Africa for the treatment of prostate disease.

December 1, 2005

Previous Page

Page 74 of 93

Next Page